Melatonin as a Possible Stimulus to Unmask an Oxytocin-Deficient State in Hypopituitarism and Hypothalamic Damage - Top-Institutions - MDSpire

Melatonin as a Possible Stimulus to Unmask an Oxytocin-Deficient State in Hypopituitarism and Hypothalamic Damage

  • By

  • Queralt Asla

  • Maite Garrido

  • Eulàlia Urgell

  • Sílvia Terzan

  • Alicia Santos

  • Nimmy Varghese

  • Cihan Atila

  • Betina Biagetti

  • Franziska Plessow

  • Mirjam Christ-Crain

  • Anne Eckert

  • Susan M Webb

  • Elizabeth A Lawson

  • Anna Aulinas

  • April 1, 2025

  • 0 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Endocrinology
    • Neuroendocrinology
    • Pituitary Disorders

  • #2

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Endocrinology
    • Neuroendocrinology
    • Neuroscience

  • #3

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Endocrinology
    • Neuroendocrinology
    • Pituitary Surgery

  • #4

    National Institutes of Health (NIH) – National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
    National Institutes of Health (NIH) – National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    Bethesda, MD

    Key Differentiators

    • Endocrinology
    • Neuroendocrinology
    • Clinical Research

  • #5

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Endocrinology
    • Neuroendocrinology
    • Neuroscience

Original Source(s)

Melatonin as a Possible Stimulus to Unmask an Oxytocin-Deficient State in Hypopituitarism and Hypothalamic Damage

  • by Queralt Asla, Maite Garrido, Eulàlia Urgell, Sílvia Terzan, Alicia Santos, Nimmy Varghese, Cihan Atila, Betina Biagetti, Franziska Plessow, Mirjam Christ-Crain, Anne Eckert, Susan M Webb, Elizabeth A Lawson, Anna Aulinas

  • April 1, 2025

Related Content

SGLT2 Inhibitors Linked to Lower Epilepsy Risk

Real-world cohort data show lower epilepsy risk vs DPP-4 inhibitors in older patients with type 2 diabetes

Combination Therapy Shows Potential in Psoriasis, Obesity

Researchers assess whether adding tirzepatide to ixekizumab affects skin and weight outcomes in adults with moderate to severe plaque psoriasis.

Medical Oddities: Disney, But Make It Clinical

From princess pathology to ICU dental cases—this lineup escalates quickly.